格隆汇7月16日丨心通医疗-B(02160.HK)公告,于2025年7月16日,公司董事会收到公司控股股东微创医疗科学有限公司("微创®",连同其附属公司统称"微创®集团")的不具约束力建议书,内容有关建议策略性重组微创集团的心律管理业务,据此,待与有兴趣人士进一步磋商、签订最终协议及取得必要同意及批准后,有关心律管理业务将并入集团业务内。截至本公告日期,董事会仍在审议及评估该建议书。集团一直...
Source Link格隆汇7月16日丨心通医疗-B(02160.HK)公告,于2025年7月16日,公司董事会收到公司控股股东微创医疗科学有限公司("微创®",连同其附属公司统称"微创®集团")的不具约束力建议书,内容有关建议策略性重组微创集团的心律管理业务,据此,待与有兴趣人士进一步磋商、签订最终协议及取得必要同意及批准后,有关心律管理业务将并入集团业务内。截至本公告日期,董事会仍在审议及评估该建议书。集团一直...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.